US BANCORP \DE\ - ACHILLION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$12,0002,000
+2339.0%
0.00%
Q4 2016$0
-100.0%
82
-83.0%
0.00%
Q1 2015$5,000
-16.7%
4820.0%0.00%
Q4 2014$6,000
-82.9%
482
-88.8%
0.00%
Q2 2013$35,0004,3190.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders